Anti-Nectin-4 Reference Antibody (enfortumab vedotin-ejfv)
Produktgrößen
100 ug
£635,00
CHB248-100UG
1 mg
£2295,00
CHB248-1MG
Über dieses Produkt
- SKU:
- CHB248
- Zusätzliche Namen:
- enfortumab vedotin-ejfv|IgG1
- Anwendung:
- Cell-based/Functional Assay, Detection/Quantitation, ELISA, FACS, Flow Cytometry
- Buffer:
- 25mM histidine, 8% sucrose, 0.01% Tween80 pH6.2
- Klonalität:
- Recombinant Monoclonal
- Konzentration:
- 1 mg/ml
- Weitere Details:
- Enfortumab vedotin-ejfv is an ADC consisting of a Nectin-4-directed antibody and Monomethyl auristatin E (MMAE) , suitable for adult patients with locally advanced or metastatic urothelial carcinoma, or who have received programmed cell death protein 1 (PD-1) inhibitor or programmed cell death ligand 1 (PD-L1) inhibitor therapy or neoadjuvant/adjuvant platinum-based chemotherapy for locally advanced or metastatic cancer.
- Formulierung:
- 25mM histidine, 8% sucrose, 0.01% Tween80 pH6.2
- Immunogen:
- Nectin-4
- Isotyp:
- IgG1
- Physischer Zustand:
- Lyophilized
- Reinheit:
- >90%
- Reaktivitäten:
- Human
- Versandbedingungen:
- Blue Ice
- Spezifität:
- Nectin-4
- Lagerbedingungen:
- -70[o]C Avoid freeze/thaw cycles., 2-8[o]C
- Hersteller:
- Sanyou Biopharmaceuticals
- Typ:
- Antibody: Biosimilar Antibody
- Datenblatt des Herstellers:CHB248